Half Of All OTCs Could Disappear From Northern Ireland Under Current Brexit Rules
UK consumer healthcare association chief Michelle Riddalls tells House of Lords peers that over half of OTC medicines could disappear from Northern Ireland's pharmacy and grocery shelves because of regulatory burdens imposed by the Brexit-related Northern Ireland Protocol.
You may also be interested in...
UK Industry Welcomes Post-Brexit ‘Windsor Framework’ For Northern Ireland
UK consumer healthcare industry association, PAGB, has welcomed the landmark “Windsor Framework” agreed by the UK and the EU, which proposes that medicines will take a “green lane” from Great Britain to Northern Ireland, while the UK regulator, MHRA, will have UK-wide responsibility for all drug approvals.
If Successful, HRA Pharma Acquisition Will Complete Perrigo’s Pivot Towards Self-Care
If its acquisition of France's HRA Pharma completes, Perrigo will have “enough growth in our back pocket for the next three to five years without making any further acquisitions,” says the firm’s UK & Ireland chief, Neil Lister, in an exclusive interview with HBW Insight.
EU OTC Batch Testing Will Continue To Be Accepted In UK, For Now
Recognition of EU/EEA batch testing of imported medicines by UK will not be ending on 1 January 2023, and companies will be given two years notice if anything changes, says MHRA.